Immunohistochemical studies of proliferating cell nuclear antigen and cathepsin d in transitional cell carcinoma of the urinary bladder

Urologia Internationalis

Volumn 59, Issue 2, 1997, Pages 81-87

  Iizumi, Tatsuo ^a   Iiyama, Tetsuro ^a   Tanaka, Wataru ^a   Okada, Eiko ^a   Kamiyama, Yutaka ^a   Okano, Yoshinori ^a   Sato, Satoshi ^a   Yazaki, Tsunetada ^a   Umeda, Takashi ^a   Imamura, Tetsuo ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bladder cancer; Cathepsin D; Immunohistochemistry; Proliferating cell nuclear antigen

Indexed keywords

ANTIBODY; CATHEPSIN D; CYCLINE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER SURVIVAL; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TRANSITIONAL CELL CARCINOMA;

EID: 0030773754     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000283030     Document Type: Article

References (33)

1. Wilson GD, McNally NJ, Dishe S, Saunders MI, Des Rochers C, Lewis AA, Bennet MH: Measurement of cell kinetics in human tumors in vivo using bromodeoxyuridinc incorporation and flow cytometry, Br J Cancer 1988;58: 423-431.
2. Yoshida K, Morinaga S, Shimosato Y, Hayata Y: A cell kinetics study of pulmonary adenocarcinoma by an immunoperoxidase procedure after bromodeoxyuridine labelling, Cancer 1989: 64:2284-2291.
3. Kerr KM, Robertson AMG, lamb D: In vitro thymidine labelling of human pulmonary neoplasms, Br J Cancer 1983:47:245-252.
4. Kerr KM, Lamb D: A comparison of patients survival and tumor growth kinetics in human bronchogenic carcinoma, Br J Cancer 1988;58: 419-422.
5. Bunn PA, Carney DN, Gazdar AF, Wang-Pcng J, Mathews MJ: Diagnostic and biological implication of flow cytometric DNA content analysis in lung cancer, Cancer Res 1983:43:5026-5032.
6. Zimmerman PV, Hawson GAT, Bint MH, Parsons PG: Ploidy as a prognostic determinant in surgically treated lung cancer, Lancet 1987:2: 530-533.
7. Mathews MB, Bcrnstin RM, Franza BR, Gar-rels JI: Identity of the proliferating cell nuclear antigen and cyclin, Nature 1984:303:374-376.
8. Waseem NH, Lane DP: Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA): Structural conservation and the detection of a nuclear form, J Cell Sci 1990:96: 121-129.
9. Hall PA, Levison DA, Woods AL, Yu CC-W, Kellock DB, Watkins JA, Barnes DM, Gillett CH, Camplcjohn R, Dover R, Waseem NH, Lane DP: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms, J Pathol 1990;162:285-294.
10. Fonlanini G, Macchiarini P, Pcpc S, Ruggiero A, Hardin M, Bigini D, Vignati S, Pingtore R, Angeletti CA: The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer, Cancer 1992:70:1520-1527.
11. Oka K, Hoshi T, Arai T: Prognostic significance of the PC 10 index as a prospective assay for cervical cancer treated with radiation therapy alone, Cancer 1992:70:1545-1550.
12. Litta LA: Tumor invasion and metastasis -Role of the extracellular matrix, Cancer Res 1986;46:1-7.
13. Dano K, Andreasen PA, Grondahl-Hanscn J, Kristensen P, Nielsen LS, Skrivcr L: Plasminogen activators, tissue degradation, and cancer, Adv Cancer Res 1985:44:139-245.
14. Sloane BF, Dunn JR, Honn KV: Lysosomal cathepsin B: Correlation with metastatic potential, Science 1981:212:1151-1153.
15. Denhardt DT, Greenberg AH, Egan SE, Hamilton RT, Wright JA: Cysteine proteinase cathepsin L expression correlates closely with the metastatic potential of H-ras-transformed murine fibroblasts, Oncogene 1987;2:55-59.
16. Thorpe SM, Rochefort H, Garcia M, Frciss G, Christensen IJ, Khalaf S, Paolucci F, Pau B, Rasmussen BB, Rose C: Association between high concentration of Mr 52.000 cathepsin D and poor prognosis in primary human breast cancer, Cancer Res 1989:49:6008-6014.
17. Isola J, Weitz S, Visakorp T, Holli K, Shea R, Khabbaz N, Kallionicmi O-P: Cathepsin D expression detected by immunohistochemistry has independent prognosis value in axillary node-negative breast cancer, J Clin Oncol 1993:11:36-43.
18. Tetu B, Brisson J, Cote C, Brisson S, Potvin D, Roberge N: Prognostic significance of cathepsin D expression in node-positive breast carcinoma: An immunohistochcmical study, Int J Cancer 1993;55:429-435.
19. Nazeer T, Malfetano JH, Rosano TG, Ross JS: Correlation of tumor cytosol cathepsin D with differentiation and invasiveness of endometrial adenocarcinoma, J Clin Pathol 1992;97: 764-769.
20. Dickinson AJ, Fox SB, Newcomb PV, Pcrsad RA, Sibley GN, Haris AL: An immunohisto-chemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas, J Urol 1995;154:237-241.
21. World Health Organization: Histological Typing of Urinary Bladder Tumors, International Classification of Tumors, Geneva, WHO, 1973, vol 10.
22. Hermanek P, Sobin LH (eds): UICC Urinary Bladder TNM Classification of Malignant Tumors, ed 3, Heidelberg, Springer, 1992, pp 274-279.
23. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations, J Am Stat Assoc 1958:53:457-481.
24. Gehan EA: A generalized Wilcoxon test for comparing arbitrarily singly-censored samples, Biometrica 1965:52:203-223.
25. Cox DR: Regression models and life tables, J R Stat Soc B 1972:34:187-220.
26. Kurki P, Ogata K, Tan EM: Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometry, J Immunol Methods 1988:109:49-59.
27. Tang J, Wong RNS: Evolution in the structure and function of aspartic proteascs, J Cell Bio-chem 1987:33:53-63.
28. Barrett AJ: Cellular proteolysis, An overview, Ann NY Acad Sci 1992;674:1-15.
29. Morissct M, Capony F, Rochefort H: Processing and estrogen regulation of the 52-kilodalton protein inside MCF7 breast cancer cells, Endocrinology 1986:119:2773-2782.
30. Capony F, Rougeot C, Montcourrier P, Ca-vailles V, Salazar G, Rochefort H: Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells, Cancer Res 1989:49:3904-3909.
31. Augereau P, Garcia M, Mattei MG, Cavailles V, Depadova F, Derocq D, Capony F, Ferrara P, Rochefort H: Cloning and sequencing of the 52K cathepsin D cDNA of MCF7 breast cancer cells and mapping on chromosome 11, Mol Endocrinol 1988:2:186-192.
32. Shipman R, Schraml P, Colombi M, Racfle G, Ludwig CU: Loss of heterozygosity on chromosome IIpi 3 in primary bladder carcinoma, Hum Genet 1993:91:455-458.
33. Sandberg AA, Berger CS: Review of chromosome studies in urological tumors II, Cytogenetics and molecular genetics of bladder cancer, J Urol 1994:151:545-560.